FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061878111> ?p ?o ?g. }

• W2061878111 endingPage "122" @default.
• W2061878111 startingPage "117" @default.
• W2061878111 abstract "Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by posttransplantation high-dose cyclophosphamide (PT-CY): the myeloablative (MA) conditioning consisted of thiotepa, busulfan, fludarabine (n = 35), or total body irradiation (TBI), fludarabine (n = 15). The median age was 42 years (range, 18-66 years); 23 patients were in remission, 27 had active disease, and 10 patients were receiving a second allograft. Graft-versus-host disease (GVHD) prophylaxis consisted in PT-CY on day +3 and +5, cyclosporine (from day 0), and mycophenolate (from day +1). Three patients died before engraftment, and 2 patients had autologous recovery: 45 patients (90%) had full-donor chimerism on day +30. The median day for neutrophil engraftment was day +18 (range, 13-30 days). The cumulative incidence of grade II-III acute GVHD (aGVHD) was 12%, and of moderate chronic GVHD (cGVHD) 10%. With a median follow-up for surviving patients of 333 days (range, 149-623 days), the cumulative incidence of transplantation-related mortality (TRM) was 18%, and the rate of relapse was 26%. The actuarial 22-month disease-free survival (DFS) rate was 68% for patients in remission and 37% for patients with active disease (P < .001). Causes of death were pneumonia (n = 3), hemorrhage (n = 3), sepsis (n = 3), and relapse (n = 7). In conclusion, an MA conditioning regimen followed by haploidentical BMT with PT-CY results in a low risk of aGVHD and cGVHD and encouraging rates of TRM and DFS." @default.
• W2061878111 created "2016-06-24" @default.
• W2061878111 creator A5003135516 @default.
• W2061878111 creator A5015539158 @default.
• W2061878111 creator A5018395647 @default.
• W2061878111 creator A5022984958 @default.
• W2061878111 creator A5025804554 @default.
• W2061878111 creator A5026031351 @default.
• W2061878111 creator A5029072398 @default.
• W2061878111 creator A5033482554 @default.
• W2061878111 creator A5039434552 @default.
• W2061878111 creator A5042348175 @default.
• W2061878111 creator A5048224601 @default.
• W2061878111 creator A5050112289 @default.
• W2061878111 creator A5069969800 @default.
• W2061878111 creator A5083379505 @default.
• W2061878111 date "2013-01-01" @default.
• W2061878111 modified "2023-10-15" @default.
• W2061878111 title "Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning" @default.
• W2061878111 cites W1693995824 @default.
• W2061878111 cites W1904996683 @default.
• W2061878111 cites W1964832115 @default.
• W2061878111 cites W1972290531 @default.
• W2061878111 cites W1987350756 @default.
• W2061878111 cites W1995905873 @default.
• W2061878111 cites W1998794592 @default.
• W2061878111 cites W2008278722 @default.
• W2061878111 cites W2015538728 @default.
• W2061878111 cites W2039334806 @default.
• W2061878111 cites W2055553511 @default.
• W2061878111 cites W2065847890 @default.
• W2061878111 cites W2076532448 @default.
• W2061878111 cites W2079023050 @default.
• W2061878111 cites W2084267226 @default.
• W2061878111 cites W2130040182 @default.
• W2061878111 cites W2134077221 @default.
• W2061878111 cites W2141696179 @default.
• W2061878111 cites W2148549851 @default.
• W2061878111 cites W2317548431 @default.
• W2061878111 doi "https://doi.org/10.1016/j.bbmt.2012.08.014" @default.
• W2061878111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22940057" @default.
• W2061878111 hasPublicationYear "2013" @default.
• W2061878111 type Work @default.
• W2061878111 sameAs 2061878111 @default.
• W2061878111 citedByCount "310" @default.
• W2061878111 countsByYear W20618781112013 @default.
• W2061878111 countsByYear W20618781112014 @default.
• W2061878111 countsByYear W20618781112015 @default.
• W2061878111 countsByYear W20618781112016 @default.
• W2061878111 countsByYear W20618781112017 @default.
• W2061878111 countsByYear W20618781112018 @default.
• W2061878111 countsByYear W20618781112019 @default.
• W2061878111 countsByYear W20618781112020 @default.
• W2061878111 countsByYear W20618781112021 @default.
• W2061878111 countsByYear W20618781112022 @default.
• W2061878111 countsByYear W20618781112023 @default.
• W2061878111 crossrefType "journal-article" @default.
• W2061878111 hasAuthorship W2061878111A5003135516 @default.
• W2061878111 hasAuthorship W2061878111A5015539158 @default.
• W2061878111 hasAuthorship W2061878111A5018395647 @default.
• W2061878111 hasAuthorship W2061878111A5022984958 @default.
• W2061878111 hasAuthorship W2061878111A5025804554 @default.
• W2061878111 hasAuthorship W2061878111A5026031351 @default.
• W2061878111 hasAuthorship W2061878111A5029072398 @default.
• W2061878111 hasAuthorship W2061878111A5033482554 @default.
• W2061878111 hasAuthorship W2061878111A5039434552 @default.
• W2061878111 hasAuthorship W2061878111A5042348175 @default.
• W2061878111 hasAuthorship W2061878111A5048224601 @default.
• W2061878111 hasAuthorship W2061878111A5050112289 @default.
• W2061878111 hasAuthorship W2061878111A5069969800 @default.
• W2061878111 hasAuthorship W2061878111A5083379505 @default.
• W2061878111 hasBestOaLocation W20618781111 @default.
• W2061878111 hasConcept C120665830 @default.
• W2061878111 hasConcept C121332964 @default.
• W2061878111 hasConcept C126322002 @default.
• W2061878111 hasConcept C141071460 @default.
• W2061878111 hasConcept C2776694085 @default.
• W2061878111 hasConcept C2776755627 @default.
• W2061878111 hasConcept C2778880498 @default.
• W2061878111 hasConcept C2779263901 @default.
• W2061878111 hasConcept C2779968505 @default.
• W2061878111 hasConcept C2780611847 @default.
• W2061878111 hasConcept C2911091166 @default.
• W2061878111 hasConcept C61511704 @default.
• W2061878111 hasConcept C71924100 @default.
• W2061878111 hasConcept C88879693 @default.
• W2061878111 hasConcept C90924648 @default.
• W2061878111 hasConceptScore W2061878111C120665830 @default.
• W2061878111 hasConceptScore W2061878111C121332964 @default.
• W2061878111 hasConceptScore W2061878111C126322002 @default.
• W2061878111 hasConceptScore W2061878111C141071460 @default.
• W2061878111 hasConceptScore W2061878111C2776694085 @default.
• W2061878111 hasConceptScore W2061878111C2776755627 @default.
• W2061878111 hasConceptScore W2061878111C2778880498 @default.
• W2061878111 hasConceptScore W2061878111C2779263901 @default.
• W2061878111 hasConceptScore W2061878111C2779968505 @default.
• W2061878111 hasConceptScore W2061878111C2780611847 @default.
• W2061878111 hasConceptScore W2061878111C2911091166 @default.

• next